Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial
暂无分享,去创建一个
Inacio Mandomando | Bart Spiessens | Mateu Espasa | Marie-Claude Dubois | Quique Bassat | Q. Bassat | C. Menéndez | M. Demoitié | J. Sacarlal | P. Aide | J. Aponte | E. Macete | P. Alonso | W. Ballou | Joe D. Cohen | A. Leach | O. Ofori-Anyinam | C. Guinovart | M. Navia | B. Spiessens | I. Mandomando | N. Tornieporth | John J Aponte | Caterina Guinovart | F. Dubovsky | Ricardo Thompson | Jahit Sacarlal | Pedro Aide | Amanda Leach | Jessica Milman | Marie-Ange Demoitié | Clara Menéndez | W Ripley Ballou | Joe Cohen | Pedro L Alonso | M. Espasa | Filip Dubovsky | Nadia Tornieporth | J. Milman | S. Corachan | M. Ceuppens | M. Dubois | Ricardo Thompson | Eusebio Macete | Opokua Ofori-Anyinam | Margarita M Navia | Sabine Corachan | Marc Ceuppens | Joe D. Cohen
[1] P. Grambsch,et al. Modeling Survival Data: Extending the Cox Model , 2000 .
[2] D. Conway,et al. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial , 2001, The Lancet.
[3] J. Palensky,et al. Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria. , 2001, The Journal of infectious diseases.
[4] Joe D. Cohen,et al. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group. , 1997, The New England journal of medicine.
[5] W. Ripley Ballou,et al. Protective Immunity Induced with Malaria Vaccine, RTS,S, Is Linked to Plasmodium falciparum Circumsporozoite Protein-Specific CD4+ and CD8+ T Cells Producing IFN-γ1 , 2003, The Journal of Immunology.
[6] K R Hess,et al. Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. , 1995, Statistics in medicine.
[7] R. Klausner,et al. An attack on all fronts , 2004, Nature.
[8] D. Kyle,et al. Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand , 1996, The Lancet.
[9] C. Drakeley,et al. Efficacy trial of malaria vaccine SPf66 in Gambian infants , 1995, The Lancet.
[10] J. F. Young,et al. Plasmodium falciparum: immunogenicity of circumsporozoite protein constructs produced in Escherichia coli. , 1987, Experimental parasitology.
[11] B. Greenwood,et al. A phase I safety and immunogenicity trial with the candidate malaria vaccine RTS,S/SBAS2 in semi-immune adults in The Gambia. , 1999, The American journal of tropical medicine and hygiene.
[12] M. Tanner,et al. Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania , 1994, The Lancet.
[13] C. Menéndez,et al. Epidemiology and clinical presentation of respiratory syncytial virus infection in a rural area of southern Mozambique , 2002, The Pediatric infectious disease journal.
[14] Anne Mills,et al. Conquering the intolerable burden of malaria: what's new, what's needed: a summary. , 2004, The American journal of tropical medicine and hygiene.
[15] Thomas A. Smith,et al. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. , 2002, The Journal of infectious diseases.
[16] M. Tanner,et al. Evaluation of the SPf66 vaccine for malaria control when delivered through the EPI scheme in Tanzania , 1999, Tropical medicine & international health : TM & IH.
[17] M. Dgedge,et al. Malaria in southern Mozambique: malariometric indicators and malaria case definition in Manhiça district. , 2003, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[18] G. Wortmann,et al. Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine. , 1998, The Journal of infectious diseases.
[19] D. Carucci,et al. Update on the clinical development of candidate malaria vaccines. , 2004, The American journal of tropical medicine and hygiene.
[20] P. Alonso,et al. Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia , 1993, The Lancet.
[21] Andrew J Tatem,et al. The global distribution and population at risk of malaria: past, present, and future. , 2004, The Lancet. Infectious diseases.
[22] A. Masuda,et al. DNA cloning of Plasmodium falciparum circumsporozoite gene: amino acid sequence of repetitive epitope. , 1984, Science.